[HTML][HTML] Off-target analysis in gene editing and applications for clinical translation of CRISPR/Cas9 in HIV-1 therapy

A Atkins, CH Chung, AG Allen, W Dampier… - Frontiers in genome …, 2021 - frontiersin.org
As genome-editing nucleases move toward broader clinical applications, the need to define
the limits of their specificity and efficiency increases. A variety of approaches for nuclease …

[HTML][HTML] Off-Target Analysis in Gene Editing and Applications for Clinical Translation of CRISPR/Cas9 in HIV-1 Therapy

A Atkins, CH Chung, AG Allen, W Dampier… - Frontiers in Genome …, 2021 - ncbi.nlm.nih.gov
As genome-editing nucleases move toward broader clinical applications, the need to define
the limits of their specificity and efficiency increases. A variety of approaches for nuclease …

Off-Target Analysis in Gene Editing and Applications for Clinical Translation of CRISPR/Cas9 in HIV-1 Therapy

A Atkins, CH Chung, AG Allen… - Frontiers in …, 2021 - researchdiscovery.drexel.edu
Off-Target Analysis in Gene Editing and Applications for Clinical Translation of CRISPR/Cas9 in
HIV-1 Therapy - Drexel University Logo image Menu Outputs New search Researchers …

Off-Target Analysis in Gene Editing and Applications for Clinical Translation of CRISPR/Cas9 in HIV-1 Therapy

A Atkins, CH Chung, AG Allen… - … in genome editing, 2021 - pubmed.ncbi.nlm.nih.gov
As genome-editing nucleases move toward broader clinical applications, the need to define
the limits of their specificity and efficiency increases. A variety of approaches for nuclease …

Off-Target Analysis in Gene Editing and Applications for Clinical Translation of CRISPR/Cas9 in HIV-1 Therapy.

A Atkins, CH Chung, AG Allen, W Dampier… - Frontiers in Genome …, 2021 - europepmc.org
As genome-editing nucleases move toward broader clinical applications, the need to define
the limits of their specificity and efficiency increases. A variety of approaches for nuclease …